Which funds hold SPTX?

As of 2026-Q2, 16 institutional funds reported holding SPTX (SEAPORT THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $190.83M.

How many shares of SPTX do institutions own?

13F filers reported 10.03M shares of SPTX, worth $190.83M in aggregate at the end of 2026-Q2.

Is institutional ownership of SPTX rising or falling?

No prior-quarter baseline is available for a directional read.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Home › Stocks › SPTX

SPTX — SEAPORT THERAPEUTICS INC

Reported value held$190.83M

Funds holding (latest)16

SectorHealth Care

Funds holding (Q2 2026)16

Institutional value$190.83M · 10.03M sh

New / Add / Cut / Exit16 / 0 / 0 / 0

Top-5 / Top-10 concentration86.9% / 98.0%

As of Q2 2026, 16 SEC-registered investment managers reported holding SPTX (SEAPORT THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $190.83M across 10.03M shares. Ownership is concentrated: the five largest holders account for 86.9% of reported value and the top ten for 98.0%.

Compared with the prior quarter, 16 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

SPTX is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Fund	Quarter	Shares	Value	Portfolio Weight	Change
Goldman Sachs Group history	Q2 2026	2.18M	$47.32M	0.00%	New
CPP Investments history	Q2 2026	1.98M	$42.91M	0.02%	New
JPMorgan Chase & Co history	Q2 2026	1.82M	$40.89M	0.01%	New
Fidelity Management & Research (FMR) history	Q2 2026	1.19M	$25.74M	0.00%	New
Principal Global Investors history	Q2 2026	414.67K	$9.01M	0.00%	New
UBS Group AG history	Q2 2026	279.18K	$6.06M	0.00%	New

BlackRock Inc history	Q2 2026	229.86K	$4.99M	0.00%	New
Citadel Advisors history	Q2 2026	191.14K	$4.15M	0.00%	New
Geode Capital Management history	Q2 2026	175.87K	$3.82M	0.00%	New
Charles Schwab Investment Management history	Q2 2026	97.69K	$2.12M	0.00%	New
Manulife Financial history	Q2 2026	82.56K	$1.79M	0.00%	New
Millennium Management history	Q2 2026	45.34K	$984.72K	0.00%	New
Northern Trust Corp history	Q2 2026	31.80K	$690.74K	0.00%	New
Morgan Stanley history	Q2 2026	11.69K	$253.95K	0.00%	New
Citigroup Inc history	Q2 2026	2.45K	$53.30K	0.00%	New
T. Rowe Price Associates history	Q2 2026	1.31M	$28.42K	0.00%	New

New Positions (Q2 2026)

Goldman Sachs Group 2.18M sh · $47.32M
CPP Investments 1.98M sh · $42.91M
JPMorgan Chase & Co 1.82M sh · $40.89M
Fidelity Management & Research (FMR) 1.19M sh · $25.74M
Principal Global Investors 414.67K sh · $9.01M
UBS Group AG 279.18K sh · $6.06M
BlackRock Inc 229.86K sh · $4.99M
Citadel Advisors 191.14K sh · $4.15M
Geode Capital Management 175.87K sh · $3.82M
Charles Schwab Investment Management 97.69K sh · $2.12M
Manulife Financial 82.56K sh · $1.79M
Millennium Management 45.34K sh · $984.72K

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 16 funds)

Fund	Q2 2026
Goldman Sachs Group	2.18M
CPP Investments	1.98M
JPMorgan Chase & Co	1.82M
Fidelity Management & Research (FMR)	1.19M
Principal Global Investors	414.67K
UBS Group AG	279.18K
BlackRock Inc	229.86K
Citadel Advisors	191.14K
Geode Capital Management	175.87K
Charles Schwab Investment Management	97.69K
Manulife Financial	82.56K
Millennium Management	45.34K
Northern Trust Corp	31.80K
Morgan Stanley	11.69K
Citigroup Inc	2.45K
T. Rowe Price Associates	1.31M

Download holders (CSV)